CHIEF COMMERCIAL OFFICER
Thu, Apr 4, 2024
Apr 4
1,008 shares @ $2.64
Decreased holdings by -25.20%
6th largest trade (out of 23)
Trade made by an officer
10b5-1 scheduled trade
Insider trade was 94% below market price
Price 43% below 200-day moving average
BTAIBioXcel Therapeutics, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W-6.81%
1M-41.45%
3M-35.36%
6M—
1Y—